Epstein Secrets

ines. The Wall Street Journal (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company, is assisting the federal government in setting up a system, called Tiberius, to track the manufacture, distribution, and ad

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ovid-19-vaccines- 11603367276> (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company, is assisting the federal government in setting up a system, called Tiberius, to track the manufacture, distribution, and adm

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ines. The Wall Street Journal (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company, is assisting the federal government in setting up a system, called Tiberius, to track the manufacture, distribution, and ad

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug